Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement

Core Points - Cosmos Health Inc. has regained compliance with Nasdaq Listing Rule 5550(a)(2), confirming a minimum bid price of $1.00 per share [1][2] - The compliance was achieved organically over 18 consecutive business days, with the closing bid price at or above $1.00 from September 22, 2025, to October 15, 2025 [2] - CEO Greg Siokas emphasized the importance of this achievement as a reflection of the company's strategic initiatives and strengthening fundamentals [3] Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada [4] - The company owns a portfolio of proprietary pharmaceutical and nutraceutical brands and operates under European Good Manufacturing Practices (GMP) [4] - Cosmos Health manufactures and distributes a wide range of pharmaceuticals and parapharmaceuticals, with a focus on R&D partnerships targeting major health disorders [4] - The company has entered the telehealth space through the acquisition of ZipDoctor, Inc. and is expanding its global distribution platform [4]